Key facts
- Synthetic Design Lab’s last known valuation is $25.0M (Jan 2024).
- It has raised $30.0M; the latest was Seed Round ($20.0M) in Apr 2025.
- Notable investors include Playground Global, Goldcrest Capital, Godfrey Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Synthetic Design Lab
- ·The full record, as it builds
Funding rounds
No funding rounds for Synthetic Design Lab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synthetic Design Lab
Developer of a therapeutic platform designed to revolutionize antibody-drug conjugates. The company's platform is engineered to optimize targeted payload delivery compared to current ADCs, potentially improving upon the efficacy, safety, and overall versatility of earlier ADCs, enabling clients to control the biophysics at the surface of a cell to enhance performance and selectivity.
- Sector
- Healthcare
- HQ
- Burlingame, CA, United States
- Founded
- 2021
- Employees
- 6
- Website
- syntheticdesignlab.com/
- Ownership
- Privately Held (backing)
Synthetic Design Lab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthetic Design Lab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthetic Design Lab in its N-PORT filings yet. We sweep new filings monthly.